Results 11 to 20 of about 46,198 (239)

Carrying a crisis: The risk of a painful sickle cell crisis during pregnancy. [PDF]

open access: yesBr J Haematol
Commentary on: Auger et al. Sickle cell anaemia with and without crises: An observational study of pregnancy outcomes. Br J Haematol. 2026;209:2264–2272.
Biemond BJ.
europepmc   +2 more sources

Apparent Stability Constant of Zr(Ⅳ)-Hydroxyurea Complex With pH Potentiometric Titration

open access: yesHe huaxue yu fangshe huaxue, 2022
Hydroxyurea(HU) is a reducing and complexing agent that can be used in the PUREX process. Zr is an important fission product in the spent fuel and main element of concern in the nuclear fuel reprocessing.
YANG Ya-ya   +7 more
doaj   +1 more source

Primary Erythrocytosis (Polycythaemia) in a Neutered Male Dog Presenting With Right Hindlimb Lameness. [PDF]

open access: yesVet Med Sci
A young dog presented with progressive unilateral hindlimb lameness and marked erythrocytosis. Diagnostic investigations excluded secondary causes and confirmed primary erythrocytosis. Targeted vascular ultrasonography identified a right external iliac venous thrombus as the suspected cause of lameness.
Belch R   +8 more
europepmc   +2 more sources

Incorporation of thymidine into onion root meristematic cell nuclei in presence of hydroxyurea and its role in recovery of mitotic activity

open access: yesActa Societatis Botanicorum Poloniae, 2015
Hydroxyurea treatment of onion roots induced mitotic block which was released by transfer of bulbs to water, and also to some extent by addition of cold or 3H-thymidine to hydroxyurea solutions.
H. Habdas
doaj   +1 more source

Hydroxyurea pharmacokinetics and precision dosing in low-resource settings

open access: yesFrontiers in Molecular Biosciences, 2023
Introduction: Hydroxyurea is effective disease-modifying treatment for sickle cell anemia (SCA). Escalation to maximum tolerated dose (MTD) achieves superior benefits without additional toxicities, but requires dose adjustments with serial monitoring ...
Luke R. Smart   +17 more
doaj   +1 more source

Cutaneous ulcers associated with hydroxyurea therapy [PDF]

open access: yes, 2013
Hydroxyurea is an antitumoral drug mainly used in the treatment of Philadelphia chromosome-negative myeloproliferative syndromes and sickle-cell disease. Ulcers represent a rare but severe long-term adverse effect of hydroxyurea therapy.
Barbanera, Sabrina   +13 more
core   +2 more sources

Oral ulcers caused by hydroxyurea [PDF]

open access: yes
We present a case of oral ulceration in a patient with essential thrombocythaemia, that proved to be secondary to treatment with hydroxyurea. This complication has not yet been reported in the ENT literature.
Lindsey L, Paleri V
core   +5 more sources

Hydroxyurea-induced hyperpigmentation with iron deposition [PDF]

open access: yes, 2019
Hydroxyurea is a chemotherapeutic agent that is used in the treatment of various hematological diseases including chronic myelogenous leukemia, polycythemia vera, and sickle cell anemia. Hydroxyurea is also used to treat psoriasis.
Vangipuram, Ramya K   +10 more
core   +1 more source

Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study

open access: yesJMIR Research Protocols, 2020
BackgroundHydroxyurea prevents disease complications among patients with sickle cell disease (SCD). Although its efficacy has been endorsed by the National Health Lung and Blood Institute evidence-based guidelines, its adoption is low, both by patients ...
Hankins, Jane S   +17 more
doaj   +1 more source

Hydroxyurea interferes with point-of-care creatinine testing in children with sickle cell anemia. [PDF]

open access: yesBMC Res Notes
Objective To evaluate the performance of the point-of-care i-STAT device for creatinine measurement in Ugandan children with sickle cell anemia (SCA), and to determine the clinical impact of hydroxyurea-associated assay interference.
Namazzi R   +8 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy